Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMetir Plc Regulatory News (MET)

Share Price Information for Metir Plc (MET)

Share Price is delayed by 15 minutes
Get Live Data
0.85    0.175 (25.93%)
Bid:
0.80
Ask:
0.90
Spread: 0.10 (12.50%)
Market Cap: £3.77m
MET Live PriceLast checked at - London Stock Exchange

Intraday Metir Plc Share Chart

Interim Trading Update

31 Jul 2025 07:00

RNS Number : 2658T
Metir PLC
31 July 2025
 

 

31 July 2025

 

Metir plc

 

("Metir" or the "Company")

 

Interim Trading Update

 

Metir plc (AIM: MET), the leading global provider of mobile and point-of-use water and environmental testing technology, is pleased to provide a trading update ahead of its interim results for the six months ending 30 June 2025 (the "Period"), which will be published in September 2025.

 

Following a year of strategic reset in 2024, in line with the Company's announcement on 29 May 2025, trading in the first half of 2025 was significantly ahead of recent prior periods. The Group's revenue for the Period was £931,000 (30 June 2024: £255,000)1. The Group's cash balance at the Period-end was £586,000, a materially improved position as a result of the successful fundraise that closed on 10 June 2025 ("Fundraise").

 

This strong revenue performance was driven by increased demand for MicroTox® LX instruments, which in turn supported a growing volume of reagent sales, representing £155,000 during the Period. In addition, revenue of £386,000 from the Group's Qatar project and the deployment of 27 Continuous Toxicity Monitors (CTMs) is being recognised in 2025. The Qatar project is due for completion by the end of the third quarter following the successful integration of upgraded software to record CTM data from the fully installed units. This project's completion marks a major milestone for the Group and establishes a strategic foothold in the Middle East.

 

The Group's operational and financial transformation, which began in 2024, is now delivering clear results in 2025. The successful rebranding to Metir plc in February 2025, alongside strengthened leadership and enhanced governance, has improved the Group's positioning to scale up production, accelerate commercialisation of new products and pursue international growth opportunities, including major toxic water testing projects. The Group raised net proceeds of £703,000 through the Fundraise, with an additional Director's contribution of £70,000 in July 2025, to support this momentum.

 

In June 2025, the Group launched its Sulphate Reducing Bacteria (SRB) kits, adding a new revenue stream to be recognised in the second half of 2025. The Group is focused on near-term revenue generation, expanding MicroTox® LX distribution, starting production of MicroTox® FX portable units and increasing associated reagent sales.

 

In parallel, commercial testing of a real-time Pathogen Detector in partnership with Aptamer Group plc is underway. The Group is also advancing its proprietary mobile PFAS testing technology in collaboration with Swansea University and a US technology partner, aiming to complete optimisation and establish Metir as the global leader in mobile PFAS detection solutions.

 

Bob Moore, Executive Chairman and Chief Executive Officer, Metir plc, commented:

 

"The Board is encouraged by the strong sales performance achieved in the first half of 2025 and remains firmly focused on scaling revenue, enhancing gross margins and progressing towards sustainable cash generation.

 

"Metir is investing prudently in infrastructure and increasing sales and marketing activity to drive future growth. The Group remains committed to increasing our market share and expanding our global footprint across the growing environmental and water testing sectors. This includes pursuing major toxic water testing opportunities, similar to the CTM deployment in Qatar, and commercialising our latest innovations.

 

"We look forward to updating investors on our continued progress in the months ahead."

 

1 The unaudited revenue for the period ended 30 June 2024 of £255,000 included income of £143,795 relating to the Qatar project, which was expected to be recognised in 2024; however in the financial results for the year ended 31 December 2024 as published on 10 July 2025, this was amended and removed due to outstanding project completion matters and payment delays in 2024, all of which were only recognised to be received in 2025.

 

- Ends -

 

Metir plc

Bob Moore, Executive Chairman and Chief Executive Officer

+44 (0) 20 3657 0050

 via Turner Pope

 

 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Alex Bond / Oliver Platts

+44 (0) 20 7496 3000

 

Turner Pope Investments (TPI) Limited (Joint Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

 

Northstar Communications (Investor Relations)

Sarah Hollins

+44 (0) 113 730 3896

 

About Metir

Metir plc is a leading global provider of mobile and point-of-use water and environmental testing technology. Through its two established divisions, Modern Water and Microsaic Systems, the Company develops and supplies innovative, easy-to-use solutions that deliver rapid, accurate water quality results, helping industries, utilities and regulators monitor safety and compliance in real time.

With a strong focus on data-driven insight and field-ready design, Metir's technology supports critical decision-making across sectors, including environmental monitoring, public health and industrial process management.

Headquartered in York, UK, Metir serves worldwide customers and is dedicated to advancing water testing standards through innovative, accessible solutions.

For more information, please visit  https://www.metirplc.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTURANRVAUBOAR
Date   Source Headline
8th Oct 20131:58 pmRNSHolding(s) in Company
23rd Sep 20137:00 amRNSHalf Yearly Report
26th Jul 20132:13 pmRNSResult of AGM
3rd Jul 20135:52 pmRNSNotice of AGM
1st Jul 20137:00 amRNSAnnual Financial Report
28th Jun 20134:45 pmRNSFinal Results
17th Apr 20137:00 amRNSDisposal
10th Apr 201311:20 amRNSProperty Disposal
2nd Nov 20123:49 pmRNSLitigation Update
29th Oct 20127:30 amRNSChange of Adviser
8th Oct 20127:00 amRNSIssue of legal proceedings
28th Sep 20127:00 amRNSHalf Yearly Report
31st Jul 201211:00 amRNSResult of AGM
27th Jul 20127:00 amRNSOffer Update
26th Jul 20126:08 pmRNSLitigation update (replacement)
26th Jul 20129:05 amRNSLitigation update
23rd Jul 20126:19 pmRNSHolding(s) in Company+Director shareholding
20th Jul 20123:36 pmRNSOffer Rejection
20th Jul 20127:00 amRNSIrrevocable undertaking to accept the Offer
19th Jul 20125:00 pmRNSOffer Document Posted
19th Jul 20127:00 amRNSCash Offer for Metro Baltic Horizons plc
2nd Jul 20129:44 amRNSAnnual Financial Report
2nd Jul 20127:00 amRNSFinal Results
20th Apr 20129:37 amRNSAppointment of New Auditor
22nd Feb 201210:05 amRNSHolding(s) in Company
9th Nov 20113:06 pmRNSResult of AGM
26th Oct 201112:03 pmRNSCorrection to Result of Annual General Meeting
25th Oct 20112:34 pmRNSResult of AGM
30th Sep 20117:00 amRNSHalf Yearly Report
29th Sep 20113:53 pmRNSNotice of AGM
10th Aug 20112:19 pmRNSHolding(s) in Company
3rd Aug 20117:30 amRNSRestoration - Metro Baltic Horizons plc
3rd Aug 20117:01 amRNSTrading Statement
3rd Aug 20117:00 amRNSFinal Results
13th May 20114:32 pmRNSDirectorate Change
12th May 20113:37 pmRNSDirectorate Change
15th Apr 20113:22 pmRNSAppointment of Director
15th Feb 201112:25 pmRNSTrading Update
2nd Dec 20103:29 pmRNSBoard Changes
15th Nov 20102:36 pmRNSResignation
15th Nov 20107:00 amRNSSuspension of Shares
11th Nov 201012:00 pmRNSTemporary Suspension
1st Nov 20109:21 amRNSAppointment of Directors
15th Oct 20103:37 pmRNSInvestment Transaction
30th Sep 20104:13 pmRNSHalf Yearly Report (Replacement)
30th Sep 20101:12 pmRNSHalf Yearly Report
27th Jul 20105:14 pmRNSResult of AGM
30th Jun 20109:21 amRNSPosting of Annual Report & Accounts
24th Jun 20101:23 pmRNSFinal Results
4th Mar 20107:00 amRNSDebt Equity Swap

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.